aTYR Pharma grants director 50,000 stock options
aTYR Pharma reported that director Paul Schimmel received a grant of stock options as part of the company’s non-employee director compensation policy.
Rhea-AI Filing Summary
aTYR Pharma reported that director Paul Schimmel received a grant of stock options as part of the company’s non-employee director compensation policy. The award covers 50,000 options to buy common stock at an exercise price of $0.95 per share, expiring on May 11, 2036.
The option vests in full on the earlier of May 11, 2027 or the company’s 2027 annual stockholders’ meeting, conditioned on his continued board service. Following this grant, Schimmel holds 50,000 stock options directly, and the filing does not show additional derivative holdings.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 50,000 shares
Grant/Award
1 txn
Insider
SCHIMMEL PAUL
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 50,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 50,000 contracts (Direct)
Footnotes (1)
- F1. The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 11, 2027 or (ii) the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
Key Figures
Options granted: 50,000 options
Exercise price: $0.95 per share
Expiration date: May 11, 2036
+3 more
6 metrics
Options granted
50,000 options
Stock Option grant on May 11, 2026
Exercise price
$0.95 per share
Conversion or exercise price of options
Expiration date
May 11, 2036
Option term end date
Underlying shares
50,000 shares
Common stock underlying the options
Post-grant derivative holdings
50,000 options
Total derivative securities following transaction
Vesting date trigger
May 11, 2027
Earlier of this date or 2027 annual meeting
Key Terms
Stock Option (right to buy), non-employee director compensation policy, exercise price, expiration date, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
non-employee director compensation policy financial
"The option, granted pursuant to the Issuer's non-employee director compensation policy"
exercise price financial
"conversion_or_exercise_price: 0.9500"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: 2036-05-11T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Board of Directors financial
"subject to the Reporting Person's continued service on the Board of Directors"
The Board of Directors is a group of people chosen by a company's owners to help make big decisions and oversee how the company is run. They act like a team of advisors or managers, making sure the company stays on track and meets its goals. Their choices can influence the company's success and how it grows.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did aTYR Pharma (ATYR) disclose about director Paul Schimmel?
aTYR Pharma disclosed that director Paul Schimmel received a grant of stock options. He was awarded 50,000 options under the non-employee director compensation policy, providing the right to buy common stock at a set exercise price if vesting conditions are met.
How many aTYR Pharma stock options were granted to Paul Schimmel?
Paul Schimmel was granted 50,000 stock options. These options give him the right to purchase 50,000 shares of aTYR Pharma common stock once they vest, aligning his compensation with the company’s equity performance over time.
What is the exercise price and expiration date of Paul Schimmel’s ATYR options?
The granted options have an exercise price of $0.95 per share and expire on May 11, 2036. This means he can buy shares at $0.95, if vested, any time before the expiration date specified in the grant.
When do Paul Schimmel’s aTYR Pharma stock options vest?
The options vest in full on the earlier of May 11, 2027 or aTYR Pharma’s 2027 annual meeting of stockholders. Vesting is contingent on his continued service on the company’s Board of Directors through that vesting date.
Is Paul Schimmel’s ATYR option grant an open-market purchase or compensation award?
The grant is a compensation-related award, not an open-market purchase. It was issued under aTYR Pharma’s non-employee director compensation policy, reflecting standard equity-based pay for board service rather than a discretionary market transaction.
How many aTYR Pharma stock options does Paul Schimmel hold after this grant?
After this grant, Paul Schimmel holds 50,000 stock options directly. The Form 4 shows these options as his derivative holdings following the transaction, with no additional derivative positions listed in the filing excerpt.
AI-generated analysis. How Rhea-AI works. Not financial advice.
